158 related articles for article (PubMed ID: 28866661)
1. Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of Corticosteroids.
Asl Baakhtari S; McCombie A; Ten Bokkel Huinink S; Irving P; Siegel CA; Mulder R; Mulder CJ; Gearry R
Dig Dis; 2018; 36(1):33-39. PubMed ID: 28866661
[TBL] [Abstract][Full Text] [Related]
2. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
3. Topical delivery of steroids in inflammatory bowel disease.
Girlich C; Scholmerich J
Curr Drug Deliv; 2012 Jul; 9(4):345-9. PubMed ID: 22762277
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort.
Ho GT; Chiam P; Drummond H; Loane J; Arnott ID; Satsangi J
Aliment Pharmacol Ther; 2006 Jul; 24(2):319-30. PubMed ID: 16842459
[TBL] [Abstract][Full Text] [Related]
5. A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis.
Tung J; Loftus EV; Freese DK; El-Youssef M; Zinsmeister AR; Melton LJ; Harmsen WS; Sandborn WJ; Faubion WA
Inflamm Bowel Dis; 2006 Dec; 12(12):1093-100. PubMed ID: 17119382
[TBL] [Abstract][Full Text] [Related]
6. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
[TBL] [Abstract][Full Text] [Related]
7. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study.
Chow DK; Sung JJ; Tsoi KK; Wong VW; Wu JC; Leong RW; Chan FK
Aliment Pharmacol Ther; 2009 Apr; 29(8):843-54. PubMed ID: 19154567
[TBL] [Abstract][Full Text] [Related]
8. [Diet therapy in chronic inflammatory bowel disease: results from meta-analysis and randomized controlled trials].
Galandi D; Allgaier HP
Praxis (Bern 1994); 2002 Nov; 91(47):2041-9. PubMed ID: 12501499
[TBL] [Abstract][Full Text] [Related]
9. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
Hanauer SB; Stathopoulos G
Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
[TBL] [Abstract][Full Text] [Related]
10. Treatment of inflammatory bowel disease with corticosteroids.
Katz JA
Gastroenterol Clin North Am; 2004 Jun; 33(2):171-89, vii. PubMed ID: 15177533
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study Group.
Humbert S; Guilpain P; Puéchal X; Terrier B; Rivière S; Mahr A; Pagnoux C; Bagnères D; Cordier JF; Le Quellec A; Altwegg R; Guillevin L;
Rheumatology (Oxford); 2015 Nov; 54(11):1970-5. PubMed ID: 26106214
[TBL] [Abstract][Full Text] [Related]
12. High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study.
Baars JE; Zelinkova Z; Mensink PB; Markus T; Looman CW; Kuipers EJ; Van Der Woude CJ
Aliment Pharmacol Ther; 2009 Oct; 30(8):864-72. PubMed ID: 19706149
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome.
Mogadam M; Dobbins WO; Korelitz BI; Ahmed SW
Gastroenterology; 1981 Jan; 80(1):72-6. PubMed ID: 6108894
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis.
Gupta V; Rodrigues R; Nguyen D; Sauk J; Khalili H; Yajnik V; Ananthakrishnan AN
Aliment Pharmacol Ther; 2016 Jan; 43(1):52-60. PubMed ID: 26541937
[TBL] [Abstract][Full Text] [Related]
15. Medical management of patients with difficult-to-treat inflammatory bowel disease.
van Hogezand RA
Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid Use in a Prospective, Community-Based Cohort of Newly Diagnosed Inflammatory Bowel Disease Patients.
Shapiro JM; Hagin SE; Shah SA; Bright R; Law M; Moniz H; Giacalone J; Jackvony T; Taleban S; Samad Z; Merrick M; Sands BE; LeLeiko NS
Dig Dis Sci; 2016 Jun; 61(6):1635-40. PubMed ID: 26725063
[TBL] [Abstract][Full Text] [Related]
17. [Presence of intracellular Escherichia coli in patients with inflammatory bowel disease].
De La Fuente M; Chahuán I; Gutiérrez R; Díaz-Jiménez D; Olivares M; Vidal R; Simian D; Figueroa C; Quera R; Hermoso MA
Rev Med Chil; 2017 Sep; 145(9):1129-1136. PubMed ID: 29424399
[TBL] [Abstract][Full Text] [Related]
18. The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD survey.
Fascì-Spurio F; Meucci G; Papi C; Saibeni S;
Dig Liver Dis; 2017 Oct; 49(10):1092-1097. PubMed ID: 28801181
[TBL] [Abstract][Full Text] [Related]
19. International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey.
Rubin DT; Sninsky C; Siegmund B; Sans M; Hart A; Bressler B; Bouhnik Y; Armuzzi A; Afzali A
Inflamm Bowel Dis; 2021 Nov; 27(12):1942-1953. PubMed ID: 33512475
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroids in inflammatory bowel disease. A review.
Routes J; Claman HN
J Clin Gastroenterol; 1987 Oct; 9(5):529-35. PubMed ID: 3316373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
